Using different cell models, we confirmed similar observations from Luca et al. [32] and Inoue et al. [33], where they enforced CXCL-8 expression in poorly tumorigenic melanoma or prostate cancer cell lines with low levels of CXCL-8, and reported enhanced tumor aggressiveness. This evidence concerns the gene CXCL8 and neoplasm.